Six months methylphenidate treatment improves emotion dysregulation in adolescents with attention deficit/hyperactivity disorder: a prospective study


Gamli I. S. , YOLGA TAHİROĞLU A.

NEUROPSYCHIATRIC DISEASE AND TREATMENT, cilt.14, ss.1329-1337, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 14
  • Basım Tarihi: 2018
  • Doi Numarası: 10.2147/ndt.s164807
  • Dergi Adı: NEUROPSYCHIATRIC DISEASE AND TREATMENT
  • Sayfa Sayıları: ss.1329-1337

Özet

Purpose: Individuals with attention deficit/hyperactivity disorder (ADHD) may suffer from emotional dysregulation (ED), although this symptom is not listed among the diagnostic criteria. Methylphenidate (MPH) is useful in reducing emotional symptoms in ADHD. The aim of the present study was to determine both psychosocial risk factors and presence of ED in adolescents with ADHD before and after MPH treatment.